Apobec1

Uses your system voice; voice and rate in settings.

Q24407191Snapshot

≈ 3 min read

Names in other languages

  • DeutschApobec1
  • EnglishApobec1
  • EspañolApobec1
  • FrançaisApobec1
  • NederlandsApobec1
  • PortuguêsApobec1
  • srnApobec1
  • SvenskaApobec1

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 also known as C->U-editing enzyme APOBEC-1 is a protein that in humans is encoded by the APOBEC1 gene. This gene encodes a member of the APOBEC protein family and the cytidine deaminase enzyme family. The encoded protein forms a multiple-protein RNA editing holoenzyme with APOBEC1 complementation factor (A1CF). This holoenzyme is involved in the editing of cytosine-to-uracil (C-to-U) nucleotide bases in apolipoprotein B and neurofibromin 1 mRNAs. APOBEC-1 (A1) has been linked with cholesterol control, cancer development and inhibition of viral replication. Its function relies on introducing a stop codon into apolipoprotein B (ApoB) mRNA, which alters lipid metabolism in the gastrointestinal tract. The editing mechanism is highly specific. A1’s deamination of the cytosine base yields uracil, which creates a stop codon in the mRNA. A1 has been linked with both positive and negative health effects. In rodents, it has wide tissue distribution where as in humans, it is only expressed in the small intestine.

Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 also known as C->U-editing enzyme APOBEC-1 is a protein that in humans is encoded by the APOBEC1 gene. This gene encodes a member of the APOBEC protein family and the cytidine deaminase enzyme family. The encoded protein forms a multiple-protein RNA editing holoenzyme with APOBEC1 complementation factor (A1CF). This holoenzyme is involved in the editing of cytosine-to-uracil (C-to-U) nucleotide bases in apolipoprotein B and neurofibromin 1 mRNAs. APOBEC-1 (A1) has been linked with cholesterol control, cancer development and inhibition of viral replication. Its function relies on introducing a stop codon into apolipoprotein B (ApoB) mRNA, which alters lipid metabolism in the gastrointestinal tract. The editing mechanism is highly specific. A1’s deamination of the cytosine base yields uracil, which creates a stop codon in the mRNA. A1 has been linked with both positive and negative health effects. In rodents, it has wide tissue distribution where as in humans, it is only expressed in the small intestine.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1361034995 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot apobec1-2746146-ebe6f609b9533fab · hash ebe6f609b9533fabcb58fc8d40c07bcaf04ba60e9d2a3c2fce28c5bbceb5d995 · captured 1782359643.0 · version history

Cite this page as: encyclopegia.org, “Apobec1”, snapshot apobec1-2746146-ebe6f609b9533fab. https://encyclopegia.org/a/apobec1

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.